We compared the rate of revision of two classes of primary anatomic shoulder arthroplasty, stemmed (aTSA) and stemless (sTSA) undertaken with cemented all polyethylene glenoid components. A large national arthroplasty registry identified two cohort groups for comparison, aTSA and sTSA between 1st January 2011 and 31st December 2020. A sub-analysis from 1 January 2017 captured additional patient demographics. The cumulative percentage revision (CPR) was determined using Kaplan-Meier estimates of survivorship and hazard ratios (HR) from Cox proportional hazard models adjusted for age and gender. Of the 7,533 aTSA procedures, the CPR at 8 years was 5.3% and for 2,567 sTSA procedures was 4.0%. There was no difference in the risk of revision between study groups (p=0.128). There was an increased risk of revision for aTSA and sTSA undertaken with humeral head sizes <44mm (p=0.006 and p=0.002 respectively). Low mean surgeon volume (MSV) (<10 cases per annum) was a revision risk for aTSA (p=0.033) but not sTSA (p=0.926). For primary diagnosis osteoarthritis since 2017, low MSV was associated with an increased revision risk for aTSA vs sTSA in the first year (p=0.048). Conversely, low MSV was associated with a decreased revision risk for sTSA in the first 6 months (p<0.001). Predominantly aTSA was revised for loosening (28.8%) and sTSA for instability/dislocation (40.6%). Revision risk of aTSA and sTSA was associated with humeral head size and mean surgeon volume but not patient characteristics. Inexperienced shoulder arthroplasty surgeons experience lower early revision rates with sTSA in the setting of osteoarthritis. Revision of aTSA and sTSA occurred for differing reasons.
Controversy about the use of an anatomical total shoulder arthroplasty
(aTSA) in young arthritic patients relates to which is the ideal
form of fixation for the glenoid component: cemented or cementless.
This study aimed to evaluate implant survival of aTSA when used
in patients aged < 60 years with primary glenohumeral osteoarthritis (OA),
and to compare the survival of cemented all-polyethylene and cementless
metal-backed glenoid components. A total of 69 consecutive aTSAs were performed in 67 patients
aged < 60 years with primary glenohumeral OA. Their mean age
at the time of surgery was 54 years (35 to 60). Of these aTSAs,
46 were undertaken using a cemented polyethylene component and 23
were undertaken using a cementless metal-backed component. The age, gender,
preoperative function, mobility, premorbid glenoid erosion, and
length of follow-up were comparable in the two groups. The patients
were reviewed clinically and radiographically at a mean of 10.3
years (5 to 12, Aims
Materials and Methods
BACKGROUND. Stability of the glenoid component is essential to ensure successful long-term outcomes following Total shoulder arthroplasty (TSA), and may be improved through better glenoid component design. As such, this study assessed identical
Purpose:. Glenoid loosening persists as a common cause of anatomic total shoulder arthroplasty (TSA) failure. Considering radiographic evidence of loosening as an endpoint, TSA has a reported survivorship of only 51.5% at 10 years. Component loosening may be related to cementation and it is postulated that poor cement penetration and heat-induced necrosis may partially be responsible. There is a growing interest among surgeons to minimize or abandon cement fixation and rely on biologic fixation to the polyethylene for long-term fixation. De Wilde et al. reported promising early clinical and radiographic results using a pegged,
Total shoulder arthroplasty (TSA) is an excellent surgical solution for patients with shoulder arthritis, providing good to excellent results in the vast majority of patients. Complications are rare, however, when they occur, can be devastating for both the patient and surgeon. An increasingly recognised complication of TSA is glenoid component failure. In a recent review of nearly 4000 shoulder arthroplasties, symptomatic glenoid component loosening occurs at a rate of 1.2% per year, while asymptomatic radiolucent lines occur at a rate of 7.3% per year. In addition, keeled glenoid components have been found to have an increased incidence of radiolucent lines compared to pegged glenoid components at both short and longer-term follow-up. Further, pegged glenoid components are associated with a lower risk of revision arthroplasty compared to keeled glenoid components. In a separate study of approximately 4600 shoulder arthroplasties, metal-backed glenoid components were found to have significantly lower rates of radiolucent lines, radiographic loosening, and component failure compared to
To report early (two-year) postoperative findings from a randomized controlled trial (RCT) investigating disease-specific quality of life (QOL), clinical, patient-reported, and radiological outcomes in patients undergoing a total shoulder arthroplasty (TSA) with a second-generation uncemented trabecular metal (TM) glenoid versus a cemented polyethylene glenoid (POLY) component. Five fellowship-trained surgeons from three centres participated. Patients aged between 18 and 79 years with a primary diagnosis of glenohumeral osteoarthritis were screened for eligibility. Patients were randomized intraoperatively to either a TM or POLY glenoid component. Study intervals were: baseline, six weeks, six-, 12-, and 24 months postoperatively. The primary outcome was the Western Ontario Osteoarthritis Shoulder QOL score. Radiological images were reviewed for metal debris. Mixed effects repeated measures analysis of variance for within and between group comparisons were performed.Aims
Methods
Introduction. the aim of this study was to analyse the long-term radiological changes following tsa in order to better understand the mechanisms responsible for loosening. Material and methods. between 1991 and 2003, in 10 European centers, 611 shoulder arthroplasties were performed for primary osteoarthritis using a third generation anatomic prosthesis with a cemented
The purpose of the study was to reduce peak cement mantle stresses occurring at the tip of the keel for an
The Mathys Affinis Short is the most frequently used stemless total shoulder prosthesis in the UK. The purpose of this prospective cohort study is to report the survivorship, clinical, and radiological outcomes of the first independent series of the Affinis Short prosthesis. From January 2011 to January 2019, a total of 141 Affinis Short prostheses were implanted in 127 patients by a single surgeon. Mean age at time of surgery was 68 (44 to 89). Minimum one year and maximum eight year follow-up (mean 3.7 years) was analyzed using the Oxford Shoulder Score (OSS) at latest follow-up. Kaplan-Meier survivorship analysis was performed with implant revision as the endpoint. Most recently performed radiographs were reviewed for component radiolucent lines (RLLs) and proximal humeral migration.Aims
Methods